Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells

Taispeáin leaganacha eile (1)

Factors that regulate the induction of apoptosis of tumour cells are potential candidates for therapeutic intervention for the majority of cancers. Studying modifiers of apoptotic responses, such as members of the tumour necrosis factor receptor superfamily, may give clues as to how induction of apo...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Cross, N, Waterman, E, Jokonya, N, Fowles, A, Buckle, C, Phillips, J, Holen, I, Hamdy, F, Eaton, C
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2008

Míreanna comhchosúla

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells.
de réir: Cross, N, et al.
Foilsithe / Cruthaithe: (2008)

Imaging the effects of castration on bone turnover and hormone-independent prostate cancer colonization of bone.
de réir: Cross, N, et al.
Foilsithe / Cruthaithe: (2008)

Human bone marrow stromal cells protect prostate and breast cancer cells from TRAIL-induced apoptosis
de réir: Nyambo, R, et al.
Foilsithe / Cruthaithe: (2004)

The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.
de réir: Cross, N, et al.
Foilsithe / Cruthaithe: (2005)

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
de réir: Nyambo, R, et al.
Foilsithe / Cruthaithe: (2004)

Analysis of the functional role of ADAMTS enzymes in prostate cancer
de réir: Molokwu, C, et al.
Foilsithe / Cruthaithe: (2005)

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers.
de réir: Waterman, E, et al.
Foilsithe / Cruthaithe: (2007)

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
de réir: Holen, I, et al.
Foilsithe / Cruthaithe: (2002)

Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
de réir: Eaton, C, et al.
Foilsithe / Cruthaithe: (2004)

Expression pattern of the ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) proteinases in human prostate cancer celllines
de réir: Chandrasekharan, S, et al.
Foilsithe / Cruthaithe: (2003)

Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
de réir: Holen, I, et al.
Foilsithe / Cruthaithe: (2002)

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
de réir: Eaton, C, et al.
Foilsithe / Cruthaithe: (2004)

Human bone marrow stromal cell derived IGF signaling enhances PSA production as well as proliferation/survival of androgen sensitive prostate cancer cells in vitro
de réir: Papageorgiou, M, et al.
Foilsithe / Cruthaithe: (2005)

EZH2 promotes proliferation and invasiveness of prostate cancer cells.
de réir: Bryant, R, et al.
Foilsithe / Cruthaithe: (2007)

Evaluating the role of ADAMTS proteoglycanases and TIMP-3 in prostate cancer progression
de réir: Adeniji, O, et al.
Foilsithe / Cruthaithe: (2007)

TIMP-3 expression is regulated by androgen and TNF in prostate stromal and cancer cells
de réir: Adeniji, O, et al.
Foilsithe / Cruthaithe: (2008)

TIMP-3 expression in prostate stromal and tumour cells is regulated by androgen and TNF
de réir: Adeniji, O, et al.
Foilsithe / Cruthaithe: (2007)

The role of osteoprotegerin in breast and prostate cancer
de réir: Holen, I, et al.
Foilsithe / Cruthaithe: (2002)

BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype.
de réir: Darby, S, et al.
Foilsithe / Cruthaithe: (2008)

OPG is a survival factor for breast- and prostate cancer cells in vitro
de réir: Holen, I, et al.
Foilsithe / Cruthaithe: (2002)

The polycomb group protein EZH2 is required for transcriptional repression of p21 and MMP7 in prostate cancer cells
de réir: Bryant, R, et al.
Foilsithe / Cruthaithe: (2007)

Trailing TRAIL Resistance: Novel Targets for TRAIL sensitization in Cancer cells
de réir: RACHANA eTRIVEDI, et al.
Foilsithe / Cruthaithe: (2015-04-01)

Qualitative and quantitative PSA mRNA detection in prostate cancer - A useful tool for the clinician?
de réir: Phillips, J, et al.
Foilsithe / Cruthaithe: (2007)

Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.
de réir: Mitchell, A, et al.
Foilsithe / Cruthaithe: (2013)

High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde
de réir: Lee Jae-Won, et al.
Foilsithe / Cruthaithe: (2011-04-01)

Bone marrow stromal cell-derived insulin-like growth factor (IGF) II enhances growth and survival of prostate cancer cells and potentiates androgen action
de réir: Cross, N, et al.
Foilsithe / Cruthaithe: (2007)

HIV induces TRAIL sensitivity in hepatocytes.
de réir: Challagundla K Babu, et al.
Foilsithe / Cruthaithe: (2009-01-01)

The emphysematous lung is abnormally sensitive to TRAIL-mediated apoptosis
de réir: Milot Julie, et al.
Foilsithe / Cruthaithe: (2011-08-01)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
de réir: Rehman, I, et al.
Foilsithe / Cruthaithe: (2008)

Differential sensitivity of normal osteoblast-like cells and osteosarcoma cells to TRAIL and an agonist antibody to TRAIL receptor-2
de réir: Locklin, R, et al.
Foilsithe / Cruthaithe: (2005)

iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.
de réir: Glen, A, et al.
Foilsithe / Cruthaithe: (2008)

Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2.
de réir: Masakatsu Oishi, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases
de réir: L.A. Braga-Silva, et al.
Foilsithe / Cruthaithe: (2009-08-01)

iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer.
de réir: Rehman, I, et al.
Foilsithe / Cruthaithe: (2012)

Diurnal variation of non-specular meteor trails
de réir: J. Hinrichs, et al.
Foilsithe / Cruthaithe: (2009-05-01)

Global variation of meteor trail plasma turbulence
de réir: L. P. Dyrud, et al.
Foilsithe / Cruthaithe: (2011-12-01)

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
de réir: Rehman, I, et al.
Foilsithe / Cruthaithe: (2004)

Trail without Catheter after Transurethral Resection of Prostate: Clamp It or Not?
de réir: Vikash Talreja, et al.
Foilsithe / Cruthaithe: (2016-01-01)

HTNV Sensitizes Host Toward TRAIL-Mediated Apoptosis—A Pivotal Anti-hantaviral Role of TRAIL
de réir: Qing-Zhou Chen, et al.
Foilsithe / Cruthaithe: (2020-06-01)

Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis
de réir: Vindrieux David, et al.
Foilsithe / Cruthaithe: (2011-12-01)